Novartis AG (NVS) 재무상태표
NYSE · Healthcare · Drug Manufacturers - General · 직원 75,267명 · CEO Vasant Narasimhan
- 주가
- $160.79 -0.19%
- 시가총액
- $3040억
- 기업가치
- $3460억
- 최근 실적
- Q3 '26 2026-10-27 제출
- 다음 실적
- 2027-02-03
Novartis AG (NVS)의 Q3 '26말 현금 및 단기투자는 $89.8억, 리스 포함 차입금은 $483억입니다. 자산총계 $1170억, 부채총계 $796억, 주주지분 $372억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $134억 | $94.7억 | $79억 | $136억 | $115억 | $70.7억 | $66.6억 | $95.6억 | $114억 | $68.8억 | $76.2억 | $88.7억 | |
| 단기투자 | $10.3억 | $2.25억 | $5.32억 | $4.11억 | $18.9억 | $1.3억 | $3.44억 | $1.97억 | $1.55억 | $1억 | $7400만 | $1.05억 | |
| 매출채권 | $81.2억 | $82.5억 | $84.8억 | $81.5억 | $82.1억 | $87.3억 | $91.8억 | $89.8억 | $109억 | $96억 | $98.5억 | $99.6억 | |
| 재고자산 | $59.1억 | $57.4억 | $57.5억 | $59.4억 | $57.2억 | $58.3억 | $63.1억 | $64.2억 | $62.7억 | $62.9억 | $62.2억 | $61억 | |
| 기타 유동자산 | $12.5억 | $27.6억 | $30.3억 | $31.6억 | $14.3억 | $33.6억 | $34.6억 | $30.4억 | $5.71억 | $37.4억 | $35.9억 | $37.1억 | |
| 유동자산 | $305억 | $264억 | $257억 | $313억 | $297억 | $251억 | $259억 | $282억 | $305억 | $266억 | $274억 | $287억 | |
| 유형자산(순액) | $109억 | $105억 | $106억 | $112억 | $109억 | $111억 | $118억 | $120억 | $124억 | $122억 | $123억 | $123억 | |
| 장기투자 | $27억 | $25.8억 | $21.3억 | $21.9억 | $11.3억 | $21억 | $21.6억 | $21.5억 | $23억 | $24.3억 | $23.7억 | $21억 | |
| 영업권 | $233억 | $231억 | $252억 | $249억 | $248억 | $250억 | $256억 | $256억 | $256억 | $268억 | $268억 | $272억 | |
| 무형자산 | $269억 | $263억 | $278억 | $279억 | $269억 | $275억 | $292억 | $290억 | $294억 | $402억 | $421억 | $398억 | |
| 이연법인세자산 | $81.9억 | $42.2억 | $44억 | $46.5억 | $43.6억 | $51억 | $52억 | $55.8억 | $54.4억 | $52.5억 | $52.8억 | $53.5억 | |
| 기타 비유동자산 | $13.1억 | $12.1억 | $16.6억 | $13.9억 | $45.1억 | $41.1억 | $44.7억 | $47.8억 | $100억 | $49.8억 | $59.3억 | $16.9억 | |
| 비유동자산 | $733억 | $679억 | $718억 | $723억 | $725억 | $748억 | $785억 | $791억 | $851억 | $919억 | $947억 | $884억 | |
| 자산총계 | $1040억 | $943억 | $975억 | $1040억 | $1020억 | $999억 | $1040억 | $1070억 | $1160억 | $1190억 | $1220억 | $1170억 | |
| 부채 | |||||||||||||
| 매입채무 | $49.3억 | $40.6억 | $41.5억 | $40.9억 | $45.7억 | $42.6억 | $45.1억 | $45.6억 | $44.6억 | $43.2억 | $42.6억 | $42.4억 | |
| 미지급비용 | $23.3억 | $0 | $0 | $0 | $21.8억 | $0 | $0 | $0 | $24.8억 | $0 | $0 | $0 | |
| 단기차입금 | $63.1억 | $83.4억 | $75.3억 | $65.7억 | $80.9억 | $78억 | $83.1억 | $75.2억 | $55.2억 | $76.2억 | $98.6억 | $96.5억 | |
| 미지급세금 | $18.9억 | $16.5억 | $19.2억 | $21.7억 | $22.3억 | $25.7억 | $28.3억 | $33.4억 | $25.8억 | $18.1억 | $0 | $26.5억 | |
| 이연수익 | $9800만 | $0 | $0 | $0 | $1.27억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 기타 유동부채 | $108억 | $150억 | $138억 | $151억 | $104억 | $167억 | $158억 | $163억 | $120억 | $174억 | $153억 | $157억 | |
| 유동부채 | $264억 | $293억 | $276억 | $281억 | $287억 | $316억 | $317억 | $320억 | $273억 | $314억 | $317억 | $325억 | |
| 장기차입금 | $184억 | $172억 | $197억 | $238억 | $214억 | $217억 | $225억 | $226억 | $296억 | $374억 | $375억 | $367억 | |
| 리스부채(비유동) | $16억 | $15.3억 | $15.6억 | $16억 | $15.7억 | $15.6억 | $15.9억 | $16.4억 | $16.6억 | $16.6억 | $16.6억 | $16.8억 | |
| 이연법인세부채 | $61.3억 | $23.1억 | $24.6억 | $22.2억 | $24.2억 | $25.5억 | $23.2억 | $21.7억 | $80.2억 | $51억 | $52.9억 | $44억 | |
| 기타 비유동부채 | $45.2억 | $42.6억 | $43.1억 | $43.9억 | $40.8억 | $41억 | $42.4억 | $41.3억 | $24.8억 | $40.2억 | $39억 | $42.8억 | |
| 비유동부채 | $307억 | $253억 | $280억 | $320억 | $294억 | $299억 | $306억 | $305억 | $417억 | $482억 | $483억 | $471억 | |
| 부채총계 | $571억 | $546억 | $556억 | $601억 | $581억 | $615억 | $623억 | $625억 | $690억 | $796억 | $801억 | $796억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $8.25억 | $7.93억 | $7.93억 | $7.93억 | $7.93억 | $7.66억 | $7.66억 | $7.66억 | $7.66억 | $7.36억 | $7.36억 | $7.36억 | |
| 이익잉여금 | $496억 | $438억 | $458억 | $463억 | $466억 | $398억 | $415억 | $435억 | $447억 | $373억 | $396억 | $392억 | |
| 기타포괄손익누계액 | -$37.7억 | -$49.4억 | -$48.7억 | -$37.3억 | $433억 | -$22.2억 | -$2.75억 | $9800만 | $6.94억 | $5.71억 | $12.1억 | -$26.9억 | |
| 주주지분 | $467억 | $397억 | $417억 | $433억 | $440억 | $384억 | $420억 | $443억 | $461억 | $385억 | $415억 | $372억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $263억 | $273억 | $290억 | $322억 | $313억 | $313억 | $326억 | $320억 | $371억 | $470억 | $490억 | $483억 | |
| 순차입금(차입금 - 현금) | $130억 | $178억 | $211억 | $186억 | $198억 | $242억 | $260억 | $225억 | $257억 | $401억 | $414억 | $394억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $70.1억 | $88.6억 | $133억 | $111억 | $96.6억 | $124억 | $75.2억 | $134억 | $115억 | $114억 | |
| 단기투자 | $7.7억 | $6.25억 | $26.9억 | $3.34억 | $19.1억 | $157억 | $111억 | $5.69억 | $18.9억 | $1.55억 | |
| 매출채권 | $102억 | $101억 | $96.8억 | $91.7억 | $90.7억 | $96.2억 | $98.9억 | $93.8억 | $82.1억 | $109억 | |
| 재고자산 | $62.6억 | $68.7억 | $69.6억 | $59.8억 | $71.3억 | $66.7억 | $71.8억 | $59.1억 | $57.2억 | $62.7억 | |
| 기타 유동자산 | $0 | $10.3억 | $32.3억 | $20.1억 | $9.63억 | $2.16억 | $3.15억 | $4.66억 | $14.3억 | $5.14억 | |
| 유동자산 | $249억 | $282억 | $356억 | $295억 | $297억 | $457억 | $369억 | $305억 | $297억 | $305억 | |
| 유형자산(순액) | $156억 | $165억 | $157억 | $137억 | $139억 | $131억 | $122억 | $109억 | $109억 | $124억 | |
| 장기투자 | $165억 | $176억 | $107억 | $110억 | $124억 | $22.7억 | $16.1억 | $18.3억 | $11.3억 | $23억 | |
| 영업권 | $310억 | $318억 | $353억 | $265억 | $300억 | $296억 | $293억 | $233억 | $248억 | $256억 | |
| 무형자산 | $313억 | $300억 | $387억 | $288억 | $368억 | $342억 | $316억 | $269억 | $269억 | $294억 | |
| 이연법인세자산 | $100억 | $82.3억 | $87억 | $79.5억 | $83.4억 | $37.4억 | $37.4억 | $43.1억 | $43.6억 | $101억 | |
| 기타 비유동자산 | $6.98억 | $8.18억 | $8.95억 | $8.97억 | $9.81억 | $31.8억 | $20.6억 | $21.8억 | $45.1억 | $54.2억 | |
| 비유동자산 | $1050억 | $1050억 | $1100억 | $889억 | $1030억 | $861억 | $805억 | $695억 | $725억 | $851억 | |
| 자산총계 | $1300억 | $1330억 | $1460억 | $1180억 | $1320억 | $1320억 | $1170억 | $999억 | $1020억 | $1160억 | |
| 부채 | |||||||||||
| 매입채무 | $48.7억 | $51.7억 | $55.6억 | $54.2억 | $54억 | $55.5억 | $51.5억 | $49.3억 | $45.7억 | $44.6억 | |
| 미지급비용 | $19.9억 | $23.3억 | $25.3억 | $24.6억 | $22.9억 | $19.7억 | $19.4억 | $19.9억 | $21.8억 | $22.5억 | |
| 단기차입금 | $59.1억 | $52억 | $96.2억 | $70.9억 | $98.8억 | $62.3억 | $58.8억 | $60.8억 | $80.9억 | $57.8억 | |
| 미지급세금 | $21.5억 | $23.8억 | $25.7억 | $21.9억 | $24.6억 | $30.3억 | $33.7억 | $24.1억 | $22.3억 | $25.8억 | |
| 이연수익 | $2.87억 | $3.05억 | $2.36억 | $1.14억 | $5600만 | $1.23억 | $1.23억 | $9800만 | $1.27억 | $0 | |
| 기타 유동부채 | $91.5억 | $86.8억 | $96.3억 | $110억 | $130억 | $124억 | $112억 | $98.4억 | $104억 | $128억 | |
| 유동부채 | $222억 | $234억 | $296억 | $283억 | $331억 | $302억 | $287억 | $264억 | $287억 | $273억 | |
| 장기차입금 | $179억 | $232억 | $225억 | $204억 | $263억 | $229억 | $202억 | $184억 | $214억 | $296억 | |
| 리스부채(비유동) | $8200만 | $0 | $0 | $17억 | $17.2억 | $16.2억 | $15.4억 | $16억 | $15.7억 | $16.6억 | |
| 이연수익(비유동) | $70.1억 | $56.7억 | $59.5억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 이연법인세부채 | $66.6억 | $51.7억 | $74.8억 | $59.1억 | $75.5억 | $30.7억 | $26.9억 | $22.5억 | $24.2억 | $80.2억 | |
| 기타 비유동부채 | $80.3억 | $65.5억 | $88.5억 | $66.3억 | $69.3억 | $61.7억 | $49.1억 | $45.2억 | $40.8억 | $24.8억 | |
| 비유동부채 | $330억 | $354억 | $373억 | $346억 | $425억 | $338억 | $294억 | $268억 | $294억 | $417억 | |
| 부채총계 | $552억 | $589억 | $669억 | $629억 | $755억 | $640억 | $580억 | $532억 | $581억 | $690억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $9.72억 | $9.69억 | $9.44억 | $9.36억 | $9.13억 | $9.01억 | $8.9억 | $8.25억 | $7.93억 | $7.66억 | |
| 이익잉여금 | $811억 | $776억 | $822억 | $593억 | $572억 | $710억 | $635억 | $496억 | $466억 | $447억 | |
| 기타포괄손익누계액 | $739억 | $733억 | $777억 | -$46.6억 | -$14.2억 | -$41.9억 | -$50억 | -$37.7억 | -$32.6억 | $6.94억 | |
| 주주지분 | $748억 | $742억 | $786억 | $555억 | $566억 | $677억 | $593억 | $467억 | $440억 | $461억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $238억 | $284억 | $321억 | $291억 | $379억 | $310억 | $279억 | $263억 | $313억 | $370억 | |
| 순차입금(차입금 - 현금) | $168억 | $196억 | $188억 | $180억 | $282억 | $186억 | $204억 | $130억 | $198억 | $256억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep.
데이터 기준일 2026-11-01